These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21695642)

  • 21. Treating patients with peripheral arterial disease and claudication.
    Treat-Jacobson D; Walsh ME
    J Vasc Nurs; 2003 Mar; 21(1):5-14; quiz 15-6. PubMed ID: 12629492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP; Anthony R; Cobb FR; Koda I; Jiao J; Hiatt WR
    J Am Coll Cardiol; 2006 Dec; 48(12):2539-45. PubMed ID: 17174195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of intermittent claudication.
    Doggrell SA
    Expert Opin Pharmacother; 2001 Nov; 2(11):1725-36. PubMed ID: 11825312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.
    Andreozzi GM; Leone A; Laudani R; Deinite G; Martini R
    Int Angiol; 2007 Mar; 26(1):12-7. PubMed ID: 17353883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies.
    Mangiafico RA; Fiore CE
    Curr Vasc Pharmacol; 2009 Jul; 7(3):394-413. PubMed ID: 19601864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of peripheral arterial disease.
    Aronow WS
    Cardiol Rev; 2005; 13(2):61-8. PubMed ID: 15705252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol.
    Donnelly R
    Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S20-5. PubMed ID: 12180354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent claudication: effective medical management of a common circulatory problem.
    Beebe HG
    Am J Cardiol; 2001 Jun; 87(12A):14D-18D. PubMed ID: 11434895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carnitine and peripheral arterial disease.
    Hiatt WR
    Ann N Y Acad Sci; 2004 Nov; 1033():92-8. PubMed ID: 15591006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK; Geroulakos G; Nicolaides AN
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cilostazol in intermittent claudication.
    Cariski AT; Lindmayer K
    Am J Health Syst Pharm; 2002 Jan; 59(1):81-2. PubMed ID: 11813475
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of cilostazol on lipid and fatty acid metabolism.
    Nakamura N; Osawa H; Yamabe H; Okumura K; Hamazaki T
    Clin Exp Med; 2005 Mar; 4(4):170-3. PubMed ID: 15750763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent claudication: new targets for drug development.
    Brass EP
    Drugs; 2013 Jul; 73(10):999-1014. PubMed ID: 23775528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication.
    Liu Y; Fong M; Cone J; Wang S; Yoshitake M; Kambayashi J
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):351-60. PubMed ID: 10975593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The case for early detection and integrated intervention in patients with peripheral arterial disease and intermittent claudication.
    Comerota AJ
    J Endovasc Ther; 2003 Jun; 10(3):601-13. PubMed ID: 12932175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies.
    Schmieder FA; Comerota AJ
    Am J Cardiol; 2001 Jun; 87(12A):3D-13D. PubMed ID: 11434894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary management of peripheral arterial disease: II. Improving walking distance and quality of life.
    Carman TL; Fernandez BB
    Cleve Clin J Med; 2006 Oct; 73 Suppl 4():S38-44. PubMed ID: 17385390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease understanding in patients with intermittent claudication: A qualitative study.
    Lokin JL; Hengeveld PJ; Conijn AP; Nieuwkerk PT; Koelemay MJ
    J Vasc Nurs; 2015 Sep; 33(3):112-8. PubMed ID: 26298615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical management of intermittent claudication.
    Casey K; Tonnessen BH; Sternbergh WC; Money SR
    Vasc Endovascular Surg; 2004; 38(5):391-9. PubMed ID: 15490035
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.